Dutch Study on Lung Cancer

Presented at the European Respiratory Society, 10/99



MADRID, SPAIN -- October 12, 1999 -- Nearly half the surgical operations on a large series of Dutch patients with lung cancer have been found to be 'futile', according to new research presented at the European Respiratory Society Annual Congress (ERS), in Madrid, Spain.

The findings have prompted the research team, led by Dr. Gerada Herder from the department of pulmonary and clinical medicine at the Free University Hospital, in Amsterdam, The Netherlands, to call for new staging processes to better identify those patients who will benefit from surgery.

In this study, the researchers staged 220 patients from a large general hospital and 117 patients from a university hospital (I/II clinically resectable, III/IV clinically unresectable) in an attempt to identify those who could benefit from surgery. Surgery was considered futile when there was a retrospective benign lesion, when there was unresectable lung cancer, or when there was relapse within 12 months after surgery with curative intent.

In all, 168 patients had surgery and 75 operations were judged to be futile. Of the patients who had surgery, 33 were found to be inoperable during surgery, 14 had a metastasis within 12 months of surgery, four developed a lymph node nodule within 12 months and the rest were found to have a benign tumour or to have developed another tumour.

The patients, whose mean age was 65, underwent a series of tests and investigations before staging including X-rays, nuclear investigations, bronchoscopy, transthoracic punction biopsies and mediastinoscopy.

In her presentation on 'Staging of non-small cell lung cancer in two large Dutch hospitals', Dr. Herder said: "Despite a thorough work up, surgery was not the effective treatment in about 50 percent of surgically reated patients in both clinical settings, and this applies to every step of the system. Better staging procedures are needed. The staging we use is not good enough, because up to a half of patients get no benefit from major unpleasant surgery such as thoracectomy."

This information is thanks to the Doctor's Guide on AOL.


Equal Survival:Shorter Chemo Course

JCO, March 2001

Elderly:Combo Chemo NO Better Survival-More Toxicity
Influence of Hospital Volume on Survival After Resection

New England J of Medicine, 7/01

Does Practice Make Perfect?
Lung Ventilation Protocol BETTER for Surgery
RadioFrequency Ablation Surgery

Terri Cranmer gets treated for NSC lung cancer(news article)

More comments from Terri and others about RFA
Terri Adds Information About Her 'Complementary' Program
Radiofrequency Ablation & Lung Cancer
Radiofrequencey Ablation: Lung Ca Tumors
Herbal Medicine

J Cancer Chemother Pharmacol, 5/03

Astragalus/Chinese Herbs & Platinum/Chemo: Non Small Cell
Meta-analysis: Astralagus/Chinese Herbs & Lung Cancer
Daphne genkwa root inhibits growth/mets Lewis lung ca (MICE)
Haishengsu and Non-Small Cell Lung Cancer
Risk of Death & Postop Radiotherapy

J Clin ONcol, 10/01 & Commentary

Radiotherapy & Stage I: Non-Small Cell
No Name
CT Scanning: Lung CA

MEDSCAPE, 4/02

References
Tumor Size & Lung Cancer Spread - Early Screening
Iressa:Cause of Death in Lung Cancer Patients

2/03 Excerpted and summarized from a Reuters Health article from Japan

Celecoxib, Medroxyprogesterone, Dietary :Lung Ca

J Pain Symptom Manage, 1/04

PET Shows Radiation-induced Changes to Lungs

J Chest, 9/05

Warm Blanket Reduces Chance of False Positives: PET Scans
Risk factors for acute esophagitis: Non-small cell Lung Ca

Int J Radiat Oncol Bio Phys, 9/06

-9 Tetrahydrocannabinol inhibits growth & metastasis of lung cancer

Abstract 4749 AACR, 2007


Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.